Terminally Ill and Patents

There was a recent article in the New York Times about a legal fight over the access rights to research drugs. Basically, the drug known as Iplex was removed from the market due to a patent dispute, and was not for sale to the public anywhere in the world.

In today’s health industry, patients have a considerable amount of access to research medicine. Keep in mind that prior to the establishment of national health departments medicine, such as the United States Food and Drug Administration (FDA), there were few regulations for the creation, testing, or distribution of drugs. Medical companies at that time could provide research drugs without knowing the major risks or implications associated with the drugs. In many cases, a drug might reduce the symptoms of an illness or disease, but would have severe side effects that would harm or even kill the patient.

This article raises the question of whether the regulations should be overridden in cases of terminally ill patents, whose very survival depends on untested drugs and unregulated procedures. Would this be a step back for patient safety, or open another avenue for survival? Should a person die while waiting for permission to use drugs whose “owners” are embroiled arguments over patent rights? How should international patent rights be handled?

For associated readings, click here.

Advertisements

About repplinger

John has served as a Reference Librarian at Willamette University since 2002. He is the liaison to the Science Departments, and is responsible for maintaining the collections related to the life & physical sciences. His research interests range over the entire spectrum of libraries and information sciences, but includes: - Google and its influence on information & society - The Internet's influence on information seeking & sharing behaviors - Trends of scholarly communication - Electronic learning environments - Traditional pedagogy - GIS use in academic libraries

Posted on May 18, 2009, in Health Info, Patents, Philosophies and tagged , , . Bookmark the permalink. Leave a comment.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: